Advanced Glycation: How are we Progressing to Combat this Web of Sugar Anomalies in Diabetic Nephropathy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3361-3372
Author(s):
Josephine M. Forbes, Vicki Thallas-Bonke, Mark E. Cooper and Merlin C. Thomas
Possible Therapeutic Targets in Cardiac Myocyte Apoptosis
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2445-2461
Author(s):
P. Andreka, Z. Nadhazi, G. Muzes, G. Szantho, L. Vandor, L. Konya, M. S. Turner, Z. Tulassay and N. H. Bishopric
Consequences of Elevated Homocysteine During Embryonic Development and Possible Modes of Action
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2719-2732
Author(s):
P. R. Brauer and B. J. Tierney
Teratological Consequences of Nitric Oxide Synthesis Inhibition
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2759-2767
Author(s):
Gian Mario Tiboni and Ettore Clementini
Resistance to Anti-VEGF Agents
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
51-64
Author(s):
Ton N. C. and Jayson G. C.
Cardiovascular Diseases and the Nitric Oxide Pathway
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
335-346
Author(s):
Silvia Llorens and Eduardo Nava
Gene Therapy for Ischemic Brain Diseases
Journal:
Current Gene Therapy
Volume:
3
Page:
49-58
Author(s):
Youichi Saitoh, Amami Kato, Yasushi Hagihara, Yasufumi Kaneda and Toshiki Yoshimine
Withdrawal Notice: Reconnoitering the Role of Endothelin in Obesity
Journal:
Current Pharmaceutical Design
Volume:
26
Page:
1-1
Author(s):
Tapan Behl*, Priya Nijhawan, Monika Sachdeva, Arun Kumar, Md. Sahab Uddin, Anita Kotwani, Gokhan Zengin, Gaurav Khullar, Himankar Sharma, Ishnoor Kaur and Sandeep Arora
Regenerative Medicine and Nanotechnology approaches against Cardiovascular Diseases: Recent Advances and Future Prospective
Journal:
Current Stem Cell Research & Therapy
Volume:
19
Page:
1-22
Author(s):
Muhammad Waseem Sajjad, Fatima Muzamil, Maida Sabir and Usman Ali Ashfaq*